Objectives: The objectives of the study were to assess the cardiovascular manifestations in hospitalized and non-hospitalized patients with COVID-19. Methods: All patients, attending to the dedicated post-COVID outpatient department of Medicine Department, Chhindwara Institute of Medical Sciences from April 2021 to March 2022, with a history of positive RTPCR for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) at least 2 weeks before presentation, were included in the study. Questionnaire along with patients echocardiogram and echo report, Canadian classification used for angina grading and NYHA classification to classify shortness of breath. A total of 650 patients were assessed for demographics, pre-existing comorbidities, health status, date of symptoms onset, COVID-19 diagnosis, health-care utilization, and the presence of any cardiac or other symptoms at the time of the onset of symptoms (retrospectively) and at follow-up days after symptoms onset. Results: The mean age of the sample (n=650) was 50.34 years. Majority were 346 (53.23%) males. According to responses using Canadian classification for chest pain were 75 (12.5%) Class 2 angina, in NYHA classification, majority 480 (80%) of patients had Class 2 SOB. About 90 (15%) of patients echo showed positive echo findings. The average stay of patients was 7.58+–1.6 days. About 135 (22.5%) of post-COVID patients had cardiac manifestations, majority were male 118 (87.4%). One hundred and two (75.5%) of patients that developed cardiac manifestation had multiple comorbidities, AF (6%) was reported in patients age 62 years and above. NSTEMI was reported in patients with multiple comorbidities. Conclusion: As the SARS-CoV-2 pandemic progresses, the interactions between coexisting cardiovascular disease and acute cardiovascular manifestations have a major implication on the medical community’s understanding of this disease. This suggests the presence of a post-COVID-19 syndrome and highlights the unmet health-care needs in a subgroup of patients with mild or severe COVID-19.
Background: Diarrhea is widely documented as a major cause of childhood morbidity and mortality in countless developing countries, particularly in India. According to the World Health Organization (WHO) report, diarrheal diseases are still leading causes of mortality and morbidity in children below 5 years of age. Objective: The present study done to estimate the association amid maternal factors and prevalence of acute diarrheal illnesses in children below 5 years of age in Chhindwara district. Methods: This community-based and cross-sectional study conducted in the urban field practice area attached to Department of Community Medicine of Chhindwara Institute of Medical Sciences, Chhindwara, from January 2019 to December 2019 was aimed to estimate the connotation between maternal factors and prevalence of acute diarrheal diseases in children under 5 years of age in Indian locations. Study tools included a pre-structured questionnaire. Baseline information of education area was taken from the Urban Primary Health Centre in the catchment area of medical college, Chhindwara. Data were arrived in Microsoft Excel spreadsheet to perform analysis. Results: In our study, 310 mothers who used to take bath daily of which 58 (19.9%) had diarrheal episodes, whereas out of 18 mothers who do not take bath daily, 11 (61.1%) had diarrheal episodes. Further, 292 mothers of children who castoff to wash their hands daily earlier the meals of which 58 (15.8%) children had diarrheal events, whereas out of 7 (38.9%) mothers who did not wash their hands before meals, 27 (12%) children had diarrheal incidents. Conclusion: The present study indicated that maternal factors bear an important impact on morbidity caused by diarrhea.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.